Cantor Fitzgerald reaffirmed their neutral rating on shares of Incyte (NASDAQ:INCY – Free Report) in a report released on Friday morning,Benzinga reports. INCY has been the subject of several other ...

Cantor Fitzgerald assumed coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research note published on Friday morning, Marketbeat reports. The firm issued an overweight ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

Cantor Fitzgerald initiated coverage of Bright Minds Biosciences (DRUG) with an Overweight rating and no price target The company’s emerging ...

Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...

Cantor Fitzgerald analyst Jonathan Ruykhaver initiated coverage of SentinelOne (S) with an Overweight rating and $30 price target. Shares have ...

Cantor Fitzgerald will pay a $6.75M fine to the Securities and Exchange Commission to settle charges that it caused two special-purpose acquisition companies it controlled “to make misleading ...

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.56% of ...